These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 16854955)
21. Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection. Cooper CL; Mills E; Angel JB AIDS; 2007 Jan; 21(1):71-6. PubMed ID: 17148970 [TBL] [Abstract][Full Text] [Related]
22. Outcomes among patients with end-stage liver disease who are coinfected with HIV and hepatitis C virus. Neff GW; Shire NJ; Rudich SM Clin Infect Dis; 2005 Jul; 41 Suppl 1():S50-5. PubMed ID: 16265614 [TBL] [Abstract][Full Text] [Related]
23. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups. Weissbrich B; Langmann P; Schubert J; Jassoy C; Klinker H Eur J Med Res; 2003 Nov; 8(11):495-8. PubMed ID: 14644704 [TBL] [Abstract][Full Text] [Related]
24. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study. Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077 [TBL] [Abstract][Full Text] [Related]
25. HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability. Shuhart MC; Sullivan DG; Bekele K; Harrington RD; Kitahata MM; Mathisen TL; Thomassen LV; Emerson SS; Gretch DR J Infect Dis; 2006 May; 193(9):1211-8. PubMed ID: 16586356 [TBL] [Abstract][Full Text] [Related]
26. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. Parsons TD; Tucker KA; Hall CD; Robertson WT; Eron JJ; Fried MW; Robertson KR AIDS; 2006 Aug; 20(12):1591-5. PubMed ID: 16868439 [TBL] [Abstract][Full Text] [Related]
28. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR; Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042 [TBL] [Abstract][Full Text] [Related]
30. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy? Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad; AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522 [TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of HIV-HCV co-infection in a large cohort of hemophiliac patients. Lichterfeld M; Schmeisser N; Qurishi N; Vogel M; Brackmann HH; Spengler U; Rockstroh JK J Infect; 2005 Apr; 50(3):221-8. PubMed ID: 15780416 [TBL] [Abstract][Full Text] [Related]
32. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331 [TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus and hepatitis C virus co-infection. Vlahakis SR J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002 [TBL] [Abstract][Full Text] [Related]
34. The liver in HIV in Africa. Feld JJ; Ocama P; Ronald A Antivir Ther; 2005; 10(8):953-65. PubMed ID: 16430201 [TBL] [Abstract][Full Text] [Related]
35. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Neuman MG; Monteiro M; Rehm J Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989 [TBL] [Abstract][Full Text] [Related]
36. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count]. Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391 [TBL] [Abstract][Full Text] [Related]
37. HIV and hepatitis C virus co-infection. Rockstroh JK; Spengler U Lancet Infect Dis; 2004 Jul; 4(7):437-44. PubMed ID: 15219554 [TBL] [Abstract][Full Text] [Related]
38. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART? Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563 [TBL] [Abstract][Full Text] [Related]
39. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors. Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ; Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298 [TBL] [Abstract][Full Text] [Related]
40. Reversibility of cirrhosis in HIV/HBV coinfection. Mallet VO; Dhalluin-Venier V; Verkarre V; Correas JM; Chaix ML; Viard JP; Pol S Antivir Ther; 2007; 12(2):279-83. PubMed ID: 17503671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]